BMAL1 and cancer: Arntl is the identified transcription factor driving the CORE-ATF6 DOWN cluster, responsible for maintenance of the circadian rhythm and has been shown to be downregulated in cancers with an association to anti-cancer roles (Extended Data Fig. 2e and Supplementary Table 5).